Immediate Parent -Infant Skin-to-Skin Study (IPISTOSS)

NCT03521310 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
91
Enrollment
OTHER
Sponsor class

Stopped Continued randomization was questioned on ethical grounds after the WHO iKMC study reported mortality reduction in May 2021. The DSMB recommended to stop the trial after reviewing a preliminary data analysis because of benefit of the intervention.

Conditions

Interventions

Sponsor

Björn Westrup, MD PhD

Collaborators